Skip to content

HCA Healthcare

NYSE: HCA · USD

HCA Healthcare cash flow and EPS100

Operating cash flow, capital investment, free cash flow and earnings per share.

Capital allocation

% of tracked cash uses

$6,016M
HCA Healthcare capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2011 Q150.23% · $329MUnavailableUnavailable4.58% · $30M45.19% · $296M100% · $655M
FY 2011 Q226.94% · $447MUnavailableUnavailable0% · $0M73.06% · $1,212M100% · $1,659M
FY 2011 Q37.2% · $394MUnavailableUnavailable0.02% · $1M92.78% · $5,075M100% · $5,470M
FY 2011 Q489.93% · $509MUnavailable0% · $0M0% · $0M10.07% · $57M100% · $566M
FY 2012 Q123.76% · $335MUnavailableUnavailable69.65% · $982M6.6% · $93M100% · $1,410M
FY 2012 Q246.58% · $449MUnavailableUnavailable0% · $0M53.42% · $515M100% · $964M
FY 2012 Q385.51% · $484MUnavailableUnavailable0.18% · $1M14.31% · $81M100% · $566M
FY 2012 Q413.17% · $594MUnavailableUnavailable47.99% · $2,165M38.84% · $1,752M100% · $4,511M
FY 2013 Q134.98% · $404MUnavailableUnavailable0.87% · $10M64.16% · $741M100% · $1,155M
FY 2013 Q294.8% · $492MUnavailableUnavailable0% · $0M5.2% · $27M100% · $519M
FY 2013 Q345.74% · $451MUnavailableUnavailable0.3% · $3M53.96% · $532M100% · $986M
FY 2013 Q462.02% · $596MUnavailableUnavailable0.31% · $3M37.67% · $362M100% · $961M
FY 2014 Q142.15% · $400MUnavailableUnavailable0.74% · $7M57.11% · $542M100% · $949M
FY 2014 Q214.86% · $513MUnavailableUnavailable0% · $0M85.14% · $2,940M100% · $3,453M
FY 2014 Q392.97% · $569MUnavailable0% · $0M0% · $0M7.03% · $43M100% · $612M
FY 2014 Q420.82% · $694MUnavailable30% · $1,000M0% · $0M49.17% · $1,639M100% · $3,333M
FY 2015 Q127.72% · $446MUnavailable22.75% · $366M0.37% · $6M49.16% · $791M100% · $1,609M
FY 2015 Q214% · $558MUnavailable14.4% · $574MUnavailable71.59% · $2,853M100% · $3,985M
FY 2015 Q352.94% · $567MUnavailable41.64% · $446MUnavailable5.42% · $58M100% · $1,071M
FY 2015 Q426.51% · $804MUnavailable33.33% · $1,011MUnavailable40.16% · $1,218M100% · $3,033M
FY 2016 Q116.21% · $509MUnavailable19.77% · $621MUnavailable64.02% · $2,011M100% · $3,141M
FY 2016 Q233.93% · $663MUnavailable63.31% · $1,237MUnavailable2.76% · $54M100% · $1,954M
FY 2016 Q320.78% · $712MUnavailable10.36% · $355MUnavailable68.86% · $2,359M100% · $3,426M
FY 2016 Q459.8% · $876MUnavailable36.72% · $538MUnavailable3.48% · $51M100% · $1,465M
FY 2017 Q155.01% · $571MUnavailable40.85% · $424MUnavailable4.14% · $43M100% · $1,038M
FY 2017 Q255.24% · $733MUnavailable40.84% · $542MUnavailable3.92% · $52M100% · $1,327M
FY 2017 Q339.56% · $729MUnavailable27.62% · $509MUnavailable32.83% · $605M100% · $1,843M
FY 2017 Q460.96% · $982MUnavailable35.75% · $576MUnavailable3.29% · $53M100% · $1,611M
FY 2018 Q153.8% · $694MUnavailable32.79% · $423M9.53% · $123M3.88% · $50M100% · $1,290M
FY 2018 Q257.78% · $880MUnavailable30.86% · $470M8.01% · $122M3.35% · $51M100% · $1,523M
FY 2018 Q330% · $846MUnavailable10.71% · $302M4.29% · $121M55% · $1,551M100% · $2,820M
FY 2018 Q469.42% · $1,153MUnavailable20.17% · $335M7.28% · $121M3.13% · $52M100% · $1,661M
FY 2019 Q162.53% · $781MUnavailable22.26% · $278M11.29% · $141M3.92% · $49M100% · $1,249M
FY 2019 Q269.25% · $964MUnavailable17.39% · $242M9.84% · $137M3.52% · $49M100% · $1,392M
FY 2019 Q316.99% · $1,139MUnavailable3.56% · $239M2.03% · $136M77.42% · $5,191M100% · $6,705M
FY 2019 Q474.2% · $1,274MUnavailable15.84% · $272M7.92% · $136M2.04% · $35M100% · $1,717M
FY 2020 Q117.87% · $853MUnavailable9.24% · $441M3.18% · $152M69.7% · $3,327M100% · $4,773M
FY 2020 Q295.15% · $745MUnavailable0% · $0M0.13% · $1M4.73% · $37M100% · $783M
FY 2020 Q392.61% · $489MUnavailable0% · $0M0% · $0M7.39% · $39M100% · $528M
FY 2020 Q495.65% · $748MUnavailable0% · $0M0% · $0M4.35% · $34M100% · $782M
FY 2021 Q127.28% · $654MUnavailable63.7% · $1,527M7.05% · $169M1.96% · $47M100% · $2,397M
FY 2021 Q212.08% · $842MUnavailable32.82% · $2,287M2.24% · $156M52.86% · $3,684M100% · $6,969M
FY 2021 Q325.96% · $889MUnavailable68% · $2,329M4.41% · $151M1.64% · $56M100% · $3,425M
FY 2021 Q434.12% · $1,192MUnavailable59.3% · $2,072M4.24% · $148M2.35% · $82M100% · $3,494M
FY 2022 Q126.86% · $861MUnavailable65.55% · $2,101M5.52% · $177M2.06% · $66M100% · $3,205M
FY 2022 Q216.5% · $1,080MUnavailable40.97% · $2,682M2.44% · $160M40.09% · $2,624M100% · $6,546M
FY 2022 Q354.56% · $1,131MUnavailable33.67% · $698M7.72% · $160M4.05% · $84M100% · $2,073M
FY 2022 Q443.32% · $1,323MUnavailable49.74% · $1,519M5.11% · $156M1.83% · $56M100% · $3,054M
FY 2023 Q143.24% · $1,197MUnavailable30.56% · $846M6.32% · $175M19.87% · $550M100% · $2,768M
FY 2023 Q252.19% · $1,241MUnavailable38.48% · $915M6.9% · $164M2.44% · $58M100% · $2,378M
FY 2023 Q345.3% · $1,147MUnavailable45.02% · $1,140M6.4% · $162M3.28% · $83M100% · $2,532M
FY 2023 Q447.36% · $1,159MUnavailable37.19% · $910M6.54% · $160M8.91% · $218M100% · $2,447M
FY 2024 Q124.58% · $1,118MUnavailable25.94% · $1,180M4.07% · $185M45.42% · $2,066M100% · $4,549M
FY 2024 Q242.39% · $1,281MUnavailable45.23% · $1,367M5.66% · $171M6.72% · $203M100% · $3,022M
FY 2024 Q336.85% · $1,191MUnavailable55.54% · $1,795M5.23% · $169M2.38% · $77M100% · $3,232M
FY 2024 Q439.98% · $1,285MUnavailable52.89% · $1,700M5.13% · $165M1.99% · $64M100% · $3,214M
FY 2025 Q113.09% · $991MUnavailable33.1% · $2,506M2.38% · $180M51.44% · $3,895M100% · $7,572M
FY 2025 Q220.94% · $1,176MUnavailable44.6% · $2,505M3.04% · $171M31.42% · $1,765M100% · $5,617M
FY 2025 Q331.22% · $1,288MUnavailable60.54% · $2,498M4.02% · $166M4.22% · $174M100% · $4,126M
FY 2025 Q425.83% · $1,489MUnavailable44.38% · $2,558M2.81% · $162M26.98% · $1,555M100% · $5,764M
FY 2026 Q138.18% · $1,119MUnavailable53.6% · $1,571M6.24% · $183M1.98% · $58M100% · $2,931M
FY 2026 Q220.46% · $1,231MUnavailable34.31% · $2,064M2.84% · $171M42.39% · $2,550M100% · $6,016M
Mar 31, 2011 through Jun 30, 2026

Operating cash flow

USD millions

$2,335M

Capital expenditures

USD millions

$1,231M

Free cash flow

USD millions

$1,104M

Stock-based compensation

USD millions

$85M

SBC / free cash flow

% · FCF before SBC deduction

7.7%

SBC / operating cash flow

%

3.64%

Software & intangible investment

USD millions

—

Separately disclosed software and intangible investment is unavailable in the extracted statements for this period.

Diluted EPS

USD per share

$7.62

Quarterly data

HCA Healthcare cash-flow history. Each metric has its own unit. A dash means inputs are missing or the calculation is undefined.
Fiscal periodEndedOperating cash flowUSD millionsCapital expendituresUSD millionsFree cash flowUSD millionsStock-based compensationUSD millionsSBC / free cash flow%SBC / operating cash flow%Software & intangible investmentUSD millionsDiluted EPSUSD per share
FY 2026 Q2Jun 30, 20262,3351,2311,104857.7%3.64%—$7.62
FY 2026 Q1Mar 31, 20262,0141,119895869.61%4.27%—$7.15
FY 2025 Q4Dec 31, 20252,3591,48987010011.49%4.24%——
FY 2025 Q3Sep 30, 20254,4161,2883,1281043.32%2.36%—$6.96
FY 2025 Q2Jun 30, 20254,2101,1763,034993.26%2.35%—$6.83
FY 2025 Q1Mar 31, 20251,6519916609814.85%5.94%—$6.45
FY 2024 Q4Dec 31, 20242,5591,2851,274856.67%3.32%——
FY 2024 Q3Sep 30, 20243,5151,1912,324763.27%2.16%—$4.88
FY 2024 Q2Jun 30, 20241,9711,28169011216.23%5.68%—$5.53
FY 2024 Q1Mar 31, 20242,4691,1181,351876.44%3.52%—$5.93
FY 2023 Q4Dec 31, 20232,6741,1591,515573.76%2.13%——
FY 2023 Q3Sep 30, 20232,4791,1471,332725.41%2.9%—$3.91
FY 2023 Q2Jun 30, 20232,4751,2411,234564.54%2.26%—$4.29
FY 2023 Q1Mar 31, 20231,8031,1976067712.71%4.27%—$4.85
FY 2022 Q4Dec 31, 20222,5271,3231,204836.89%3.28%——
FY 2022 Q3Sep 30, 20223,0201,1311,889874.61%2.88%—$3.91
FY 2022 Q2Jun 30, 20221,6301,0805508515.45%5.21%—$3.9
FY 2022 Q1Mar 31, 20221,3458614848617.77%6.39%—$4.14
FY 2021 Q4Dec 31, 20212,4431,1921,251997.91%4.05%——
FY 2021 Q3Sep 30, 20212,2778891,3881158.29%5.05%—$7
FY 2021 Q2Jun 30, 20212,2518421,4091299.16%5.73%—$4.36
FY 2021 Q1Mar 31, 20211,9886541,334977.27%4.88%—$4.14
FY 2020 Q4Dec 31, 2020-3,583748-4,331133————
FY 2020 Q3Sep 30, 20202,7174892,228813.64%2.98%—$1.95
FY 2020 Q2Jun 30, 20208,7237457,978660.83%0.76%—$3.16
FY 2020 Q1Mar 31, 20201,3758535228215.71%5.96%—$1.69
FY 2019 Q4Dec 31, 20192,5051,2741,231846.82%3.35%—$3.09
FY 2019 Q3Sep 30, 20192,1261,13998710510.64%4.94%—$1.76
FY 2019 Q2Jun 30, 20191,9979641,033969.29%4.81%—$2.25
FY 2019 Q1Mar 31, 20199747811936232.12%6.37%—$2.97
FY 2018 Q4Dec 31, 20182,1751,1531,022646.26%2.94%—$3.01
FY 2018 Q3Sep 30, 20181,721846875708%4.07%—$2.15
FY 2018 Q2Jun 30, 20181,5828807027410.54%4.68%—$2.31
FY 2018 Q1Mar 31, 20181,300694606609.9%4.62%—$3.18
FY 2017 Q4Dec 31, 20171,734982752759.97%4.33%—$1.3
FY 2017 Q3Sep 30, 20171,0087292795519.71%5.46%—$1.15
FY 2017 Q2Jun 30, 20171,404733671679.99%4.77%—$1.75
FY 2017 Q1Mar 31, 20171,2805717097310.3%5.7%—$1.74
FY 2016 Q4Dec 31, 20161,699876823556.68%3.24%—$2.39
FY 2016 Q3Sep 30, 20161,2067124946713.56%5.56%—$1.59
FY 2016 Q2Jun 30, 20161,349663686649.33%4.74%—$1.65
FY 2016 Q1Mar 31, 20161,399509890657.3%4.65%—$1.69
FY 2015 Q4Dec 31, 20151,558804754689.02%4.36%—$1.4
FY 2015 Q3Sep 30, 20151,1015675346812.73%6.18%—$1.05
FY 2015 Q2Jun 30, 20151,0575584995511.02%5.2%—$1.18
FY 2015 Q1Mar 31, 20151,018446572488.39%4.72%—$1.36
FY 2014 Q4Dec 31, 20141,627694933454.82%2.77%—$1.19
FY 2014 Q3Sep 30, 2014—569—41———$1.16
FY 2014 Q2Jun 30, 20141,250513737405.43%3.2%—$1.07
FY 2014 Q1Mar 31, 2014443400433786.05%8.35%—$0.76
FY 2013 Q4Dec 31, 20131,226596630325.08%2.61%—$0.92
FY 2013 Q3Sep 30, 2013900451449306.68%3.33%—$0.79
FY 2013 Q2Jun 30, 2013814492322288.7%3.44%—$0.91
FY 2013 Q1Mar 31, 2013740404336236.85%3.11%—$0.74
FY 2012 Q4Dec 31, 20121,263594669172.54%1.35%—$0.68
FY 2012 Q3Sep 30, 2012655484171169.36%2.44%—$0.78
FY 2012 Q2Jun 30, 20121,4604491,011141.38%0.96%—$0.85
FY 2012 Q1Mar 31, 201279733546291.95%1.13%—$1.18
FY 2011 Q4Dec 31, 20111,38750987820.23%0.14%—$4.25
FY 2011 Q3Sep 30, 201188039448681.65%0.91%—$0.11
FY 2011 Q2Jun 30, 201174844730182.66%1.07%—$0.43
FY 2011 Q1Mar 31, 201191832958981.36%0.87%—$0.52
Sources and calculations

Financial inputs from company filings. Last checked Oct 19, 2026. A dash means missing inputs or an undefined calculation.

Period changes use the preceding fiscal quarter or year. Percentage changes divide by the absolute prior value; a zero or missing baseline has no percentage change. Percentage metrics show changes in percentage points.

FCF subtracts reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Acquisitions and noncash lease additions are excluded. EPS and weighted shares are not summed across quarters. Annual figures use annual reports.

SBC / FCF always uses FCF before SBC deduction; both SBC ratios compare amounts from the same period. A zero or negative cash-flow denominator is undefined, and values above 100% are retained.

Each reported nonnegative cash use / sum of available tracked nonnegative cash uses × 100. Missing categories are omitted, never set to zero. This is the composition of tracked uses, not a complete cash-flow reconciliation or a percentage of OCF. SBC is noncash and excluded. Negative amounts are excluded as reversals or net receipts; they are not converted to spending. Annual bars use reported annual amounts. Turning off a category hides its share without changing the denominator. Debt repayments prefer a reported aggregate, with long-term or convertible-only scope identified in the tooltip. Acquisitions are net of cash acquired. Dividend payments use the aggregate where reported, including dividend equivalents when part of that concept.

The SBC option subtracts reported share-based compensation from FCF as an economic-cost scenario. Missing SBC never becomes zero.

Market prices: Yahoo Finance · HCA, USD. Latest completed close Oct 22, 2026. Price data retrieved Oct 23, 2026.

Operating cash flow
Reported net cash provided by or used in operating activities.
Capital expenditures
Reported cash capital investment. Uses purchases of property, plant and equipment where disclosed; otherwise purchases of productive assets, which can also include software and intangibles. Excludes acquisitions and noncash lease additions.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Stock-based compensation
Reported share-based compensation addback in the cash-flow statement. Missing disclosure is not treated as zero.
SBC / free cash flow
Reported share-based compensation / (operating cash flow − cash capital investment) × 100, for the same fiscal period. Always uses FCF before SBC deduction. Zero or negative FCF is undefined; values above 100% are retained.
SBC / operating cash flow
Reported share-based compensation / reported operating cash flow × 100, for the same fiscal period. Zero or negative operating cash flow is undefined. Unaffected by the SBC deduction scenario.
Software & intangible investment
Separately tagged payments for capitalized software under US GAAP, or purchases of intangible assets under IFRS. This optional disclosure is not inferred from total capex or deducted a second time from FCF.
Diluted EPS
Reported diluted earnings per share, normalized for recorded subsequent stock splits. Quarterly EPS is never subtracted from annual or YTD EPS.